| Recruiting | 1 | 917 | Japan | AB122, TAS-116, TAS-120, TAS-115, TAS-102, Ramucirumab, Bevacizumab, Fluorouracil, Cisplatin, AB154, Carboplatin, nab-Paclitaxel, Gemcitabine | Taiho Pharmaceutical Co., Ltd. | Advanced or Metastatic Solid Tumor, Pancreatic Ductal Adenocarcinoma, Colorectal Cancer, Non-small Cell Lung Cancer, Gastric Cancer, Alveolar Soft Part Sarcoma, Esophageal Cancer, Head and Neck Cancer, Biliary Tract Cancer | 05/26 | 05/26 | | |
| Withdrawn | 1 | 27 | US | Palbociclib Oral Product, TAS-116 | Brown University | Advanced Breast Cancer, Treatment-Refractory Solid Tumors, Retinoblastoma Deficiency, SCLC, Soft Tissue Sarcoma, Endometrial Cancer, Bladder Cancer | 08/24 | 08/24 | | |
| Active, not recruiting | 1 | 48 | Japan | Zejula (niraparib) - GSK, J&J, Jeselhy (pimitespib) - Otsuka | National Cancer Center Hospital East, Takeda Pharmaceutical Co., Ltd. | unresectable recurrent solid tumor | | | | |
| Recruiting | 1 | 78 | Japan, RoW | Pimitespib, TAS-116, Imatinib, Sunitinib | Taiho Pharmaceutical Co., Ltd. | Gastrointestinal Stromal Tumors | 12/25 | 12/25 | | |
